A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
The Fed Won’t Talk About Rate Cuts. Why Traders Are Betting on Them.
2023-11-28 06:27
A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
You Might Like...
Scientists unearth a secret hidden within the Mona Lisa
Save 55% on a refurbished ThinkPad with Microsoft Office Pro
‘Game-changing’ facial recognition technology catches prolific shoplifters
Chinese hackers seeking to disrupt communications between US and Asia in event of crisis, Microsoft says
Broadband Network Gigaclear Draws Up to £420 Million Investment
Meta sells Giphy to Shutterstock to comply with UK regulator order
Learn Python from home with this $20 expert-led bundle
Rare six-foot fish sighting sparks ‘doomsday’ theories